292 related articles for article (PubMed ID: 10683128)
1. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
[TBL] [Abstract][Full Text] [Related]
2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
3. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
4. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
5. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
7. New treatment options for CMV retinitis in AIDS.
Lalezari JP
Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
[No Abstract] [Full Text] [Related]
8. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
9. Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.
Jabs DA; Martin BK; Forman MS;
Ophthalmology; 2010 Jan; 117(1):128-132.e2. PubMed ID: 19818505
[TBL] [Abstract][Full Text] [Related]
10. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
Jacobson MA
Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712
[No Abstract] [Full Text] [Related]
11. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
[TBL] [Abstract][Full Text] [Related]
13. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
14. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
Wagstaff AJ; Bryson HM
Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325
[TBL] [Abstract][Full Text] [Related]
15. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir.
Berman SM; Kim RC
Am J Med; 1994 May; 96(5):415-9. PubMed ID: 8192172
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
18. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group in collaboration with AIDS Clinical Trials Group.
J Infect Dis; 1995 Sep; 172(3):613-21. PubMed ID: 7658051
[TBL] [Abstract][Full Text] [Related]
20. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
